000			02120nam a2200505 i 4500
001			ocn681770033
003			OCoLC
005			20190831111939.0
006			m o d f
007			cr bn||||||ada
008			101117s1993 mdua ob f000 0 eng c
019			_a624651249
040			_aOCLCE _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCO _dOCLCQ _dGILDS _dOCLCO _dOCLCF _dOCLCA _dGPO _dMvI
042			_adlr _apcc
043			_an-us---
074			_a0831-C-12 (online)
086	0		_aHE 20.3965:136 _zHE 20.8216:136
099			_aHE 20.3965:136
245	0	0	_aAssessing neurotoxicity of drugs of abuse / _ceditor: Lynda Erinoff.
264		1	_aRockville, MD : _bU.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse, _c1993.
300			_a1 online resource (vi, 281 pages) : _billustrations.
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aNIDA research monograph ; _v136
490	1		_aNIH publication ; _vno. 93-3644
504			_aIncludes bibliographical references.
500			_aCRDP Program record.
588			_aDescription based on online resource, PDF version; title from title page (NIDA, viewed April 3, 2019).
650		0	_aNeurotoxicology _zUnited States.
650		0	_aNeuropharmacology _zUnited States.
650		0	_aDrugs of abuse _xToxicology _zUnited States.
650		0	_aDrug abuse _xHealth aspects _zUnited States.
650		0	_aNeuroplasticity.
650		7	_aNeuropharmacology _xResearch. _2fast _0(OCoLC)fst01036460
650		7	_aNeurotoxicology _xResearch. _2fast _0(OCoLC)fst01036562
651		7	_aUnited States. _2fast _0(OCoLC)fst01204155
700	1		_aErinoff, Lynda, _eeditor.
710	2		_aNational Institute on Drug Abuse, _eissuing body.
776	0	8	_iPrint version: _tAssessing neurotoxicity of drugs of abuse _w(DLC) 93246201 _w(OCoLC)29307989
830		0	_aNIDA research monograph ; _v136.
830		0	_aNIH publication ; _vno. 93-3644.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo118900
949			_aBEV _bFed Docs
999			_c285676 _d285676